论文信息 - Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. - 字舞流文

Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.

S. Pannullo | A. Tsiouris | J. Boockvar | P. Christos | E. Lavi | R. Kaplan | K. Kesavabhotla | B. Shin | R. Scheff | C. Schlaff | Lynn Mubita